Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-038112
Filing Date
2024-03-28
Accepted
2024-03-28 16:35:03
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A coya_defa14a_notice_and_.htm DEFA14A 24951
2 GRAPHIC img105378183_0.jpg GRAPHIC 309775
3 GRAPHIC img105378183_1.jpg GRAPHIC 269772
  Complete submission text file 0000950170-24-038112.txt   824334
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-41583 | Film No.: 24799715
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)